.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Molecular Cancer Therapeutics
Prendergast
€ 180.21
FREE Delivery in Ireland
Description for Molecular Cancer Therapeutics
Hardcover. Promotes an understanding of steps involved in developing drug leads for industrial partnering and development. This work provides an overview of the strategies for discovery and validation of drug target molecules, and discusses cell and molecule based drug screening strategies, as well as mouse models for cancer. Editor(s): Prendergast, George C. Num Pages: 352 pages, Illustrations. BIC Classification: MJ; PN; PS. Category: (P) Professional & Vocational. Dimension: 255 x 185 x 23. Weight in Grams: 852.
Molecular Cancer Therapeutics covers state-of-the-art strategies to identify and develop cancer drug target molecules and lead inhibitors for clinical testing. It provides a thorough treatment of drug target discovery, validation, and development. The introductory chapters provide an overview of pathways to discovery and development of molecular cancer therapeutics. Subsequent chapters progress from initial stages of drug target discovery to drug discovery, development, and testing in preclinical and clinical models. Topics include drug lead screening, drug-to-lead development, proof-of-concept studies, medicinal chemistry issues, intellectual property concerns, and clinical development.
This invaluable reference promotes understanding of steps involved in developing drug leads ... Read more
Molecular Cancer Therapeutics covers state-of-the-art strategies to identify and develop cancer drug target molecules and lead inhibitors for clinical testing. It provides a thorough treatment of drug target discovery, validation, and development. The introductory chapters provide an overview of pathways to discovery and development of molecular cancer therapeutics. Subsequent chapters progress from initial stages of drug target discovery to drug discovery, development, and testing in preclinical and clinical models. Topics include drug lead screening, drug-to-lead development, proof-of-concept studies, medicinal chemistry issues, intellectual property concerns, and clinical development.
This invaluable reference promotes understanding of steps involved in developing drug leads ... Read more
Product Details
Format
Hardback
Publication date
2004
Publisher
John Wiley and Sons Ltd United States
Number of pages
352
Condition
New
Number of Pages
368
Place of Publication
New York, United States
ISBN
9780471432029
SKU
V9780471432029
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-50
About Prendergast
Dr. George C. Prendergast was a Benjamin Franklin Scholar at the University of Pennsylvania and graduated magna cum laude with distinction in biochemistry in 1983. He received an M.S. in molecular biophysics and biochemistry from Yale University in 1984 and a Ph.D. in molecular biology from Princeton University in 1989. He was an American Cancer Society Postdoctoral Fellow at the ... Read more
Reviews for Molecular Cancer Therapeutics
"…this little book represents the ever-so-important 'and' that links research and development together in a logical and thoughtful manner...a valuable resource for scientists and clinicians alike…" (New England Journal of Medicine, January 27, 2005) "...an excellent publication.… I recommended it for libraries...those involved in cancer research...those who teach pharmacy and medical students about drugs used in the treatment of ... Read more